News

Demand for NO2 sterilization grows and new facility is booked through 2024 Noxilizer announces the availability of NO2 contract sterilization in the United States at their Hanover, MD headquarters. This facility is conveniently located next to the Baltimore Washington International Airport and in close proximity to global pharmaceutical companies and some of the leading contract […]

Special Opportunity to Evaluate the Leading Alternative Sterilization Method for Medical Devices — Nitrogen Dioxide (NO2) Gas Many companies have a corporate initiative underway to evaluate alternative sterilization methods. Noxiizer has been working with a number of global medical device companies to test their current products, as well as new materials for products in development.

Noxilizer announces that multiple pharmaceutical and biotech companies have completed or are in the process of completing sterilization validation of products that will be submitted to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) starting in early 2023. This marks further advancement in the adoption of nitrogen dioxide (NO₂) sterilization. NO₂ sterilization is rapidly becoming